Duloxetine
- Product NDC
- 67877-265
- 11-digit product format
- 678770265
- Labeler code
- 67877
- Product ID
- 67877-265_958fae45-5e7a-4f8b-80b7-5934222747b5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Duloxetine
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Labeler
- Ascend Laboratories, LLC
- Application
- ANDA203197
- Marketing category
- ANDA
- Marketing start
- 2012-05-01
- Substance
- DULOXETINE HYDROCHLORIDE
- Active strength
- 60 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Duloxetine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DULOXETINE HYDROCHLORIDE | 60 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9044SC542W |
| Rxcui | 596926, 596930, 596934 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 67877-265-01 | Duloxetine | 100 in 1 BOTTLE | CAPSULE, DELAYED RELEASE | 100 | | 24 |
| 67877-265-10 | Duloxetine | 1000 in 1 BOTTLE | CAPSULE, DELAYED RELEASE | 1000 | | 24 |
| 67877-265-30 | Duloxetine | 30 in 1 BOTTLE | CAPSULE, DELAYED RELEASE | 30 | | 24 |
| 67877-265-90 | Duloxetine | 90 in 1 BOTTLE | CAPSULE, DELAYED RELEASE | 90 | | 24 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| DULOXETINE HYDROCHLORIDE | ACTIVE INGREDIENT | 9044SC542W | DULOXETINE CAPSULE, DELAYED RELEASE [ASCEND LABORATORIES, LLC] | 8 | |
| DULOXETINE | ACTIVE MOIETY | O5TNM5N07U | DULOXETINE CAPSULE, DELAYED RELEASE [ASCEND LABORATORIES, LLC] | 8 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | DULOXETINE CAPSULE, DELAYED RELEASE [ASCEND LABORATORIES, LLC] | 8 | |
| AMMONIA | INACTIVE INGREDIENT | 5138Q19F1X | DULOXETINE CAPSULE, DELAYED RELEASE [ASCEND LABORATORIES, LLC] | 8 | |
| BUTYL ALCOHOL | INACTIVE INGREDIENT | 8PJ61P6TS3 | DULOXETINE CAPSULE, DELAYED RELEASE [ASCEND LABORATORIES, LLC] | 8 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | DULOXETINE CAPSULE, DELAYED RELEASE [ASCEND LABORATORIES, LLC] | 8 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | DULOXETINE CAPSULE, DELAYED RELEASE [ASCEND LABORATORIES, LLC] | 8 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | DULOXETINE CAPSULE, DELAYED RELEASE [ASCEND LABORATORIES, LLC] | 8 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | DULOXETINE CAPSULE, DELAYED RELEASE [ASCEND LABORATORIES, LLC] | 8 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | DULOXETINE CAPSULE, DELAYED RELEASE [ASCEND LABORATORIES, LLC] | 8 | |
| HYDROXYPROPYL CELLULOSE (TYPE H) | INACTIVE INGREDIENT | RFW2ET671P | DULOXETINE CAPSULE, DELAYED RELEASE [ASCEND LABORATORIES, LLC] | 8 | |
| HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST) | INACTIVE INGREDIENT | 87Y6436BKR | DULOXETINE CAPSULE, DELAYED RELEASE [ASCEND LABORATORIES, LLC] | 8 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | DULOXETINE CAPSULE, DELAYED RELEASE [ASCEND LABORATORIES, LLC] | 8 | |
| ISOPROPYL ALCOHOL | INACTIVE INGREDIENT | ND2M416302 | DULOXETINE CAPSULE, DELAYED RELEASE [ASCEND LABORATORIES, LLC] | 8 | |
| METHYLENE CHLORIDE | INACTIVE INGREDIENT | 588X2YUY0A | DULOXETINE CAPSULE, DELAYED RELEASE [ASCEND LABORATORIES, LLC] | 8 | |
| POTASSIUM HYDROXIDE | INACTIVE INGREDIENT | WZH3C48M4T | DULOXETINE CAPSULE, DELAYED RELEASE [ASCEND LABORATORIES, LLC] | 8 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | DULOXETINE CAPSULE, DELAYED RELEASE [ASCEND LABORATORIES, LLC] | 8 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | DULOXETINE CAPSULE, DELAYED RELEASE [ASCEND LABORATORIES, LLC] | 8 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | DULOXETINE CAPSULE, DELAYED RELEASE [ASCEND LABORATORIES, LLC] | 8 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | DULOXETINE CAPSULE, DELAYED RELEASE [ASCEND LABORATORIES, LLC] | 8 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | DULOXETINE CAPSULE, DELAYED RELEASE [ASCEND LABORATORIES, LLC] | 8 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | DULOXETINE CAPSULE, DELAYED RELEASE [ASCEND LABORATORIES, LLC] | 8 | |
| TRIETHYL CITRATE | INACTIVE INGREDIENT | 8Z96QXD6UM | DULOXETINE CAPSULE, DELAYED RELEASE [ASCEND LABORATORIES, LLC] | 8 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 67877-265 | DULOXETINE CAPSULE, DELAYED RELEASE [ASCEND LABORATORIES, LLC] | 22 | Current NDC, Legacy NDC, 4 package rows | 20231130_e6477c41-97a2-45a7-94b5-487aa65199f6.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67877-265-01 | 67877026501 | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (67877-265-01) | 2012-05-01 | 0000-00-00 | No | No | Current |
| 67877-265-10 | 67877026510 | 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (67877-265-10) | 2012-05-01 | 0000-00-00 | No | No | Current |
| 67877-265-30 | 67877026530 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (67877-265-30) | 2012-05-01 | 0000-00-00 | No | No | Current |
| 67877-265-90 | 67877026590 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (67877-265-90) | 2012-05-01 | 0000-00-00 | No | No | Current |